Arkis BioSciences® achieves FDA clearance of its new CerebroFlo™ EVD Catheter with Endexo® Technology

Arkis BioSciences, a leading innovator in minimally invasive surgical instrumentation, has obtained FDA clearance of its new external ventricular drainage catheter, CerebroFlo™.  The CerebroFlo catheter has demonstrated a 99% reduction in thrombus accumulation in-vitro, and is indicated for temporary use in patients with elevated intracranial pressure, intraventricular hemorrhage, or hydrocephalic shunt infections. Arkis will debut the CerebroFlo EVD Catheter at the upcoming Congress of Neurological Surgeons (booth 747), in Boston MA, October 7-11, 2017.

View the full press release


Contact Us

Address:  P.O. Box 9815, 1 Momentum Way, Knoxville, TN 37920   |    Tel: (844) 247-5383 (toll free)

 © Arkis Biosciences   |    Privacy   |    Sitemap


Go to top